gw pharmaceuticals ceo: cannabis as a cure | mad money | cnbc
Published 9 years ago • 8.3K plays • Length 7:34Download video MP4
Download video MP3
Similar videos
-
8:08
gw pharmaceuticals ceo: ‘real science’ in cannabis | mad money | cnbc
-
7:28
gw pharmaceuticals ceo: defining cbd and thc-based drugs | mad money | cnbc
-
7:12
gw pharmaceuticals ceo: a ‘big step’ forward | mad money | cnbc
-
6:33
gw pharmaceuticals ceo: pot play | mad money | cnbc
-
6:44
growforce ceo and mjardin chairman: managing cannabis | mad money | cnbc
-
4:39
gw pharma ceo on new cannabis-derived drug
-
1:59
epidiolex sales, potential cbd treatment for ptsd and more: gw pharma ceo
-
7:03
gw pharma ceo: europe epidyolex launch | mad money | cnbc
-
3:55
‘wonder plant’: medical cannabis use jumps from 3.9 to 30 per cent
-
10:19
3 top marijuana stock picks
-
7:46
canopy growth ceo: informed by science | mad money | cnbc
-
2:12
gw pharma ceo explains company's plan for cbd-based epilepsy drug
-
6:52
corbus pharmaceuticals ceo: manmade cannabinoids | mad money | cnbc
-
1:04
gw pharma ceo: need to know more on benefits of cannabis-derived drugs
-
3:59
paradigm shift in weed industry, says jim cramer
-
6:16
green thumb industries ceo: ‘credentializing’ cannabis | mad money | cnbc
-
8:07
gw pharmaceuticals, cannabis patents, fda and dea
-
8:21
canopy growth ceo: vaping regulations | mad money | cnbc
-
4:50
gw pharmaceuticals - hot or not
-
6:44
green growth brands ceo: breaking into cannabis retail | mad money | cnbc
-
4:15
jim cramer on jazz pharmaceuticals buying gw pharma for $7.2 billion